A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback